Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance
The Poly (ADP-ribose) polymerase (PARP) family has many essential functions in cellular
processes, including the regulation of transcription, apoptosis and the DNA damage …
processes, including the regulation of transcription, apoptosis and the DNA damage …
PARP and PARG inhibitors in cancer treatment
D Slade - Genes & development, 2020 - genesdev.cshlp.org
Oxidative and replication stress underlie genomic instability of cancer cells. Amplifying
genomic instability through radiotherapy and chemotherapy has been a powerful but …
genomic instability through radiotherapy and chemotherapy has been a powerful but …
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
There are more than 70 distinct sarcomas, and this diversity complicates the development of
precision-based therapeutics for these cancers. Prospective comprehensive genomic …
precision-based therapeutics for these cancers. Prospective comprehensive genomic …
BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality
Mutations in the tumor-suppressor genes BRCA1 and BRCA2 resulting in BRCA1/2
deficiency are frequently identified in breast, ovarian, prostate, pancreatic, and other …
deficiency are frequently identified in breast, ovarian, prostate, pancreatic, and other …
Protein post-translational modifications in the regulation of cancer hallmarks
Posttranslational modifications (PTMs) of proteins, the major mechanism of protein function
regulation, play important roles in regulating a variety of cellular physiological and …
regulation, play important roles in regulating a variety of cellular physiological and …
BRCAness revisited
CJ Lord, A Ashworth - Nature Reviews Cancer, 2016 - nature.com
Over the past 20 years, there has been considerable progress in our understanding of the
biological functions of the BRCA1 and BRCA2 cancer susceptibility genes. This has led to …
biological functions of the BRCA1 and BRCA2 cancer susceptibility genes. This has led to …
Ewing's sarcoma
N Riggi, ML Suvà, I Stamenkovic - New England Journal of …, 2021 - Mass Medical Soc
Ewing's Sarcoma Ewing's sarcoma, an aggressive cancer of bone and soft tissue, primarily
affects children and young adults. A t (11; 22) translocation is noted in 85 to 90% of cases …
affects children and young adults. A t (11; 22) translocation is noted in 85 to 90% of cases …
Ewing sarcoma: current management and future approaches through collaboration
N Gaspar, DS Hawkins, U Dirksen, IJ Lewis… - Journal of Clinical …, 2015 - ascopubs.org
Ewing sarcoma (ES) is an aggressive sarcoma of bone and soft tissue occurring at any age
with a peak incidence in adolescents and young adults. The treatment of ES relies on a …
with a peak incidence in adolescents and young adults. The treatment of ES relies on a …
Review of various NAMPT inhibitors for the treatment of cancer
Y Wei, H **ang, W Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in the NAD
salvage pathway of mammalian cells and is overexpressed in numerous types of cancers …
salvage pathway of mammalian cells and is overexpressed in numerous types of cancers …
EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
Ewing sarcoma is an aggressive paediatric cancer of the bone and soft tissue. It results from
a chromosomal translocation, predominantly t (11; 22)(q24: q12), that fuses the N-terminal …
a chromosomal translocation, predominantly t (11; 22)(q24: q12), that fuses the N-terminal …